Salk Institute scientists developed an improved workflow for characterizing capsids (genome-containing protein cones) in HIV-1 (the most common form of HIV). This novel workflow incorporates advanced technology that will allow scientists to better understand how capsid morphology changes in response to distinct pressures and to pinpoint new, more effective ways to target capsids and treat HIV-1. Importantly, the workflow can also be used to study structural changes in other, non-HIV viruses.

Nuclear medicine imaging, like (SPECT), scans the body’s interior to track organ function or detect disease. Current tools for nuclear medicine imaging are expensive and difficult to manufacture. New tool captures sharp, high-resolution signals of fine features at a fraction of the cost.

Pennington Biomedical Research Center is proud to announce that Dr. Steven B. Heymsfield, Professor of Metabolism and Body Composition, has been named a Boyd Professor of Louisiana State University – the highest faculty rank and honor awarded within the LSU System.

Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide and claiming hundreds of thousands of lives each year. A growing body of evidence now points to an intricate connection between energy metabolism and immune regulation as a driving force behind the onset, progression, and treatment resistance of these cancers. The latest comprehensive review on this topic underscores the potential of targeting these intertwined processes to unlock more effective therapies.

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis.